Tag: In the News,Non-Small Cell Lung Cancer,OSI,Pharmaceuticals,Roche,Tarceva,biomarker,blood-based cancer test,cancer diagnostics,lung cancer,molecular diagnostic,oncology,personalized medicine
-
Blood Test Helps Target Roche/OSI Lung Cancer Drug (Reuters)
Blood analysis good at predicting how tumours will respond; Proteomic test useful when doctors have no tumour tissue